Arbutus Biopharma CorporationArbutus Biopharma CorporationArbutus Biopharma Corporation

Arbutus Biopharma Corporation

No trades
See on Supercharts

ABUS fundamentals

Arbutus Biopharma Corporation revenue breakdown overview

Arbutus Biopharma Corporation revenue for the last year amounted to 6.17 M USD, the most of which — 6.17 M USD — came from its highest performing source at the moment, Novel Therapeutics, the year earlier bringing 18.14 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Arbutus Biopharma Corporation 6.17 M USD, and the year before that — 18.14 M USD.

By source
By country